ClinicalTrialsFinder

NRAS Q61K Clinical Trials in Nashville, Tennessee

1 recruitingNashville, Tennessee

Showing 1–1 of 1 trials

Recruiting
Phase 1

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

NRAS MutationNRAS Q61RNRAS Q61K+8 more
Relay Therapeutics, Inc.35 enrolled6 locationsNCT07584226